Fulcrum Therapeutics (FULC) EBIT (2018 - 2026)
Fulcrum Therapeutics' EBIT was -$29.31 million in Q2 2026, compared with -$19.82 million a year earlier.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) EBIT (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fulcrum Therapeutics' EBIT was -$96.05 million through Jun 30, 2026; for FY2025, it was -$84.77 million.
- In earlier years, EBIT was -$21.9 million in FY2024, -$110.66 million in FY2023, -$112.56 million in FY2022 and -$81.05 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT since Q1 2024.
- Per Business Quant data, FULC's EBIT in the three quarters before Q2 2026 was -$22.19 million (Q1 2026), -$22.69 million (Q4 2025) and -$21.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Fulcrum Therapeutics | 282.56 Mn | -60.78 Mn | - | -29.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.31 Mn |
| Mar 31, 2026 | -22.19 Mn |
| Dec 31, 2025 | -22.69 Mn |
| Sep 30, 2025 | -21.86 Mn |
| Jun 30, 2025 | -19.82 Mn |
| Mar 31, 2025 | -20.40 Mn |
| Dec 31, 2024 | -19.43 Mn |
| Sep 30, 2024 | -25.13 Mn |
| Jun 30, 2024 | 52.49 Mn |
| Mar 31, 2024 | -29.83 Mn |
| Dec 31, 2023 | -27.99 Mn |
| Sep 30, 2023 | -27.44 Mn |
| Jun 30, 2023 | -27.29 Mn |
| Mar 31, 2023 | -27.94 Mn |
| Dec 31, 2022 | -27.97 Mn |
| Sep 30, 2022 | -24.36 Mn |
| Jun 30, 2022 | -34.24 Mn |
| Mar 31, 2022 | -26.00 Mn |
| Dec 31, 2021 | -23.56 Mn |
| Sep 30, 2021 | -20.77 Mn |
API Access
Fulcrum Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();